AMCP Nexus: The Academy of Managed Care Pharmacy Nexus

Dr Lametra Scott Discusses Cost, Formulary Guidance in Managing Sickle Cell Disease

October 23, 2020

While sickle cell disease is not prevalent in the general population, the significant cost associated with the condition warrants action from payers and formulary decision makers to improve patient access and align cost with their budgetary goals.

Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs

October 23, 2020

In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.

Understanding the Complicated Patchwork of State Drug Pricing Reform Legislation

October 23, 2020

The pressure on state budgets exerted by new approvals of costly therapeutics has led many states to implement legislation aimed at regulating drug prices, but the success of these efforts is not uniform across the nation.

Succeeding in Value-Based Payment Requires Engaging Pharmacists From Health Plans and Systems

October 21, 2020

Pharmacists have an important role to play in the success of value-based payment models, according to panelists who discussed their health plan’s value initiatives at the Academy of Managed Care Pharmacy Nexus 2020 meeting.

Examining Payer Strategies, Impact on Managing Specialty Medications

October 21, 2020

For pharmacy practices to effectively manage specialty drugs, an extensive staff of pharmacists with clinical and managed care expertise is needed, as well as a collaborative effort between all those involved in the care team.

Daniel Nam on Post–COVID-19 Implications for Managed Care Pharmacy

October 21, 2020

In assessing a post–coronavirus disease 2019 (COVID-19) world, several aspects may impact managed care pharmacy practices long-term, including self-administration of therapies and issues in pharmacy reimbursement spotlighted by the pandemic.